Abstract
Breast liver metastases are uncommon and have not been well reported. We studied the clinical outcome of 47 patients who developed liver metastases out of 912 breast cancer patients treated between 1982 and 1987, an incidence of 5.2%. The median disease free interval prior to clinical liver metastases was 20.2 months (range 4-192 months). The most frequent clinical presentations were hepatomegaly (70%) and abdominal pain (34%). The diagnosis was confirmed on ultrasound scan in 72.7% patients. Thirty-one patients (70.5%) received specific treatment with both hormone and chemotherapy but only six showed any evidence of objective response, the majority of whom had metastases only in the liver. The median survival of treated patients was 4 months and absence of jaundice, response to treatment and liver metastases only were associated with significantly better survival. In conclusion breast liver metastases usually present as a manifestation of disseminated disease and have an appalling prognosis. When they occur as an initial site the prognosis is better but very few patients overall respond to conventional treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alderson P. O., Adams D. F., McNeil B. J., Sanders R., Siegelman S. S., Finberg H. J., Hessel S. J., Abrams H. L. Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison. Radiology. 1983 Oct;149(1):225–230. doi: 10.1148/radiology.149.1.6611929. [DOI] [PubMed] [Google Scholar]
- Clark C. P., 3rd, Foreman M. L., Peters G. N., Cheek J. H., Sparkman R. S. Efficacy of peroperative liver function tests and ultrasound in detecting hepatic metastasis in carcinoma of the breast. Surg Gynecol Obstet. 1988 Dec;167(6):510–514. [PubMed] [Google Scholar]
- Cutler S. J., Ardyce J. A., Taylor S. G., 3rd Classification of patients with disseminated cancer of the breast. Cancer. 1969 Nov;24(5):861–869. doi: 10.1002/1097-0142(196911)24:5<861::aid-cncr2820240502>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- De Rivas L., Coombes R. C., McCready V. R., Gazet J. C., Ford H. T., Neville A. M., Powels T. J. Tests for liver metastases in breast cancer: evaluation of liver scan and liver ultrasound. Clin Oncol. 1980 Sep;6(3):225–230. [PubMed] [Google Scholar]
- Drum D. E., Beard J. M. Scintigraphic criteria for hepatic metastases from cancer of the colon and breast. J Nucl Med. 1976 Aug;17(8):677–680. [PubMed] [Google Scholar]
- FENSTER L. F., KLATSKIN G. Manifestations of metastatic tumors of the liver. A study of eighty-one patients subjected to needle biopsy. Am J Med. 1961 Aug;31:238–248. doi: 10.1016/0002-9343(61)90112-7. [DOI] [PubMed] [Google Scholar]
- Jaffe B. M., Donegan W. L., Watson F., Spratt J. S., Jr Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968 Jul;127(1):1–11. [PubMed] [Google Scholar]
- Kamby C., Dirksen H., Vejborg I., Daugaard S., Guldhammer B., Rossing N., Mouridsen H. T. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer. 1987 Apr 15;59(8):1524–1529. doi: 10.1002/1097-0142(19870415)59:8<1524::aid-cncr2820590823>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Kamby C. The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors. Cancer Treat Rev. 1990 Mar;17(1):37–61. doi: 10.1016/0305-7372(90)90075-q. [DOI] [PubMed] [Google Scholar]
- Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
- Nemoto T., Dao T. L. Significance of liver metastasis in women with disseminated breast cancer undergoing endocrine ablative surgery. Cancer. 1966 Mar;19(3):421–427. doi: 10.1002/1097-0142(196603)19:3<421::aid-cncr2820190316>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Patanaphan V., Salazar O. M., Risco R. Breast cancer: metastatic patterns and their prognosis. South Med J. 1988 Sep;81(9):1109–1112. [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schreve R. H., Terpstra O. T., Ausema L., Lameris J. S., van Seijen A. J., Jeekel J. Detection of liver metastases. A prospective study comparing liver enzymes, scintigraphy, ultrasonography and computed tomography. Br J Surg. 1984 Dec;71(12):947–949. doi: 10.1002/bjs.1800711212. [DOI] [PubMed] [Google Scholar]
- Smith T. J., Kemeny M. M., Sugarbaker P. H., Jones A. E., Vermess M., Shawker T. H., Edwards B. K. A prospective study of hepatic imaging in the detection of metastatic disease. Ann Surg. 1982 Apr;195(4):486–491. doi: 10.1097/00000658-198204000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Viadana E., Bross I. D., Pickren J. W. An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer. 1973 Apr;27(4):336–340. doi: 10.1038/bjc.1973.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warnes T. W. Alkaline phosphatase. Gut. 1972 Nov;13(11):926–937. doi: 10.1136/gut.13.11.926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zinser J. W., Hortobagyi G. N., Buzdar A. U., Smith T. L., Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol. 1987 May;5(5):773–782. doi: 10.1200/JCO.1987.5.5.773. [DOI] [PubMed] [Google Scholar]